ziltivekimab: Clinical Trials

9 trials of ziltivekimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting, 2 recruiting, 1 terminated. 6 Phase 3, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Active not recruiting 2, Recruiting 2, Completed 1, Terminated 1
Phase 22Completed 2
Phase 11Completed 1

Follow ziltivekimab: new trials by email Literature Review of ziltivekimab trials Research Report on ziltivekimab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Ziltivekimab, Placebo - Coronary Artery Disease, Acute Myocardial Infarction (AMI)
Phase 3RecruitingECRI bv3322025-12-192026-03-23
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
Ziltivekimab, Ziltivekimab Placebo - Myocardial Infarction
Phase 3RecruitingNovo Nordisk A/S3322025-12-182026-03-11
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Ziltivekimab, Placebo - Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3Active not recruitingNovo Nordisk A/S100002024-06-252026-09-09
Specifying the Anti-inflammatory Effects of Ziltivekimab
Ziltivekimab, Placebo - Atherosclerosis, Inflammation
Phase 3CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)402024-05-032026-11-06
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
Ziltivekimab, Placebo - Heart Failure, Systemic Inflammation
Phase 3Active not recruitingNovo Nordisk A/S6732024-04-012026-10-01
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Ziltivekimab, Placebo - Heart Failure
Phase 3TerminatedNovo Nordisk A/S48742023-05-082026-10-01
A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation
Ziltivekimab, Placebo - Chronic Kidney Disease and Systemic Inflammation
Phase 1CompletedNovo Nordisk A/S242022-05-302025-12-31
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
Ziltivekimab, Placebo (ziltivekimab) - Chronic Kidney Disease, Inflammation
Phase 2CompletedNovo Nordisk A/S362020-10-222026-05-06
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition
Ziltivekimab - Chronic Kidney Diseases, Inflammation
Phase 2CompletedNovo Nordisk A/S2642019-06-032025-12-31

Conditions studied

Inflammation (3)  ·  Renal Insufficiency, Chronic (3)  ·  Atherosclerosis (2)  ·  Heart Failure (2)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Myocardial Infarction (1)

Sponsors

Novo Nordisk A/S (7)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  ECRI bv (1)

Countries

Netherlands (4)  ·  Spain (4)  ·  United States (4)  ·  Argentina (3)  ·  Australia (3)  ·  Bulgaria (3)  ·  Canada (3)  ·  China (3)  ·  Czechia (3)  ·  Denmark (3)  ·  France (3)  ·  Germany (3)  ·  Greece (3)  ·  India (3)  ·  Italy (3)

Top investigators

Ernest Spitzer, MD (1)

Results publications

PMID 34015342, PMID 35212585, PMID 37211246, PMID 38088558, PMID 39073758, PMID 41805697

NIH funding

2023 (2)